Nasopharyngeal Cancer
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Phase II Trial Comparing Immunotherapy Versus Capecitabine Maintenance After Chemo-chemoradiotherapy for High-risk Nasopharyngeal Carcinoma [Phase 2]
Phase II trial is testing immunotherapy versus capecitabine maintenance after chemo-chemoradiotherapy in high-risk nasopharyngeal cancer; pa…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer [Phase 2]
This Phase 2 clinical trial is evaluating BMX-001 as a radioprotector added to standard chemoradiation therapy for head and neck cancers and…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors
A clinical trial update from MD Anderson describes ongoing recruitment for a study assessing functional and symptom outcomes in survivors of…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
This clinical trial update describes the use of blood tests and questionnaires to study adherence to preventative swallowing exercises in pa…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Becotatug Vedotin (MRG003) With PD-1 Blockade and Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial evaluating Becotatug Vedotin (MRG003) in combination with a PD-1 blocker and chemoradiotherapy for high-risk locoregionally ad…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers [Phase 2, Phase 3]
This clinical trial update describes a Phase 2/Phase 3 study evaluating atezolizumab and/or bevacizumab with or without standard chemotherap…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer [Phase 4]
This is a Phase 4 clinical trial evaluating toripalimab in combination with cisplatin and gemcitabine for recurrent/metastatic nasopharyngea…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers
This entry describes the Head and Neck Registry within the European Reference Network for Rare Adult Solid Cancers, a recruiting registry st…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer [Phase 1]
Phase 1 trial evaluating TMV vaccine therapy alone and with pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma; cu…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Autologous Dendritic Cells and Allogenic Dendritic Secretomes for Patients With Advanced Nasopharyngeal Cancer [Phase 1, Phase 2]
Phase 1/Phase 2 trial evaluating autologous dendritic cells and allogenic dendritic secretomes for advanced nasopharyngeal cancer; the study…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating BL-B01D1 in patients with metastatic or unresectable non-small cell lung cancer and other solid tumors is …
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: AI System for Anatomic Recognition & Lesion Detection in Nasopharyngolaryngoscopy: A Prospective Study
This clinical trial update describes a prospective study to evaluate an AI system for anatomic recognition and lesion detection during nasop…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Salvage Locoregional Radiotherapy in De Novo Metastatic NPC [Phase 3]
A Phase 3 trial is evaluating a PD-1 inhibitor plus chemotherapy, followed by immediate versus salvage locoregional radiotherapy in patients…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Randomised Trial of Induction Gemcitabine and Cisplatin Versus Gemcitabine, Cisplatin, Pembrolizumab and Bevacizumab (GPPB) in Nasopharyngeal Cancer [Phase 2]
Phase 2 randomized trial comparing induction Gemcitabine and Cisplatin versus Gemcitabine, Cisplatin, Pembrolizumab, and Bevacizumab in naso…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients
This clinical trial update announces recruitment for a study aiming to identify biomarkers that predict how cancer patients respond to radia…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer
An international collaborative study is validating the AJCC/UICC TNM-10 staging system for nasopharyngeal cancer, and it is currently not re…
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Nivolumab in Nasopharyngeal Cancer With Progression During or After Platinum-based Treatment [Phase 2]
Phase 2 clinical trial evaluating nivolumab for nasopharyngeal cancer in patients who progressed during or after platinum-based treatment; t…
-
CLINICAL_TRIALS research · 2025-02-17Clinical Trial Update: A Deep Learning Model for Diagnosing Lymph Node Metastasis in Nasopharyngeal Carcinoma(NPC)
A clinical trial is evaluating a deep learning model to diagnose lymph node metastasis in nasopharyngeal cancer, and the study is currently …
-
CLINICAL_TRIALS research · 2025-02-04Clinical Trial Update: Predictive Tools in Head and Neck Cancer Patients Undergoing Radiotherapy
Clinical trial update describing the use of predictive tools to guide radiotherapy in head and neck cancer patients. The study is currently …
-
CLINICAL_TRIALS research · 2024-10-29Clinical Trial Update: Arabic PRO Measures for Head and Neck Cancer Radiotherapy.
A trial investigating Arabic patient-reported outcome measures for radiotherapy in head and neck cancer patients; currently recruiting.
-
CLINICAL_TRIALS research · 2024-09-26Clinical Trial Update: U87 CAR-T in Patients With Advanced Head and Neck Tumors [Phase 1]
A Phase 1 clinical trial is evaluating U87 CAR-T therapy in patients with advanced head and neck tumors, including nasopharyngeal cancer, an…
-
CLINICAL_TRIALS research · 2018-12-04Clinical Trial Update: A Research About Nutrition Impact for Local Advanced Nasopharyngeal Carcinoma Patients [Phase 4]
A Phase 4 trial update exploring nutrition impact in local advanced nasopharyngeal carcinoma patients.
-
CLINICAL_TRIALS research · 2018-05-14Clinical Trial Update: Appaconitine Patch for Oral Mucositis Pain Caused by Chemoradiotherapy in Patients With Nasopharyngeal Cancer [NA]
This document reports an ongoing clinical trial of Appaconitine Patch for radiation-induced oral mucositis pain in nasopharyngeal cancer pat…
-
CLINICAL_TRIALS research · 2017-02-10Clinical Trial Update: Photon/Proton Radiation Therapy for Carcinoma of the Nasopharynx
A clinical trial evaluating photon and proton radiation therapy for nasopharyngeal cancer has been terminated. The study (NCT00797290) was s…
-
CLINICAL_TRIALS research · 2015-10-30Clinical Trial Update: Nimotuzumab in Combination With Chemoradiation for Nasopharyngeal Cancer [Phase 3]
Phase 3 clinical trial evaluating nimotuzumab in combination with chemoradiation for nasopharyngeal cancer; current status is UNKNOWN accord…